Cargando…
Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives
[Image: see text] 2-Aminobenzochromenes and dihydropyranochromenes represent a unique class of biologically active compounds. Recent organic syntheses focus on the development of environmentally benign synthetic protocols, and as a part of this concept, we have taken a considerable interest in the s...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979373/ https://www.ncbi.nlm.nih.gov/pubmed/36873031 http://dx.doi.org/10.1021/acsomega.2c06049 |
_version_ | 1784899716010475520 |
---|---|
author | Cholayil Palapetta, Surya Gurusamy, Harichandran Ganapasam, Sudhandiran |
author_facet | Cholayil Palapetta, Surya Gurusamy, Harichandran Ganapasam, Sudhandiran |
author_sort | Cholayil Palapetta, Surya |
collection | PubMed |
description | [Image: see text] 2-Aminobenzochromenes and dihydropyranochromenes represent a unique class of biologically active compounds. Recent organic syntheses focus on the development of environmentally benign synthetic protocols, and as a part of this concept, we have taken a considerable interest in the synthesis of this class of biologically active compounds using an environment-friendly, reusable heterogeneous Amberlite IRA 400-Cl resin catalyst. This work further aims to highlight the importance and advantages of these compounds and to compare the experimental data obtained with those of the theoretical calculations made using the density functional theory (DFT) method. Molecular docking studies on the selected compounds were also carried out to study the effectiveness of these compounds in liver fibrosis treatment. Furthermore, we have performed molecular docking studies and an in vitro study of the anticancer activity of dihydropyrano[3,2-c]chromenes and 2-aminobenzochromenes against human colon cancer cells [HT29]. |
format | Online Article Text |
id | pubmed-9979373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-99793732023-03-03 Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives Cholayil Palapetta, Surya Gurusamy, Harichandran Ganapasam, Sudhandiran ACS Omega [Image: see text] 2-Aminobenzochromenes and dihydropyranochromenes represent a unique class of biologically active compounds. Recent organic syntheses focus on the development of environmentally benign synthetic protocols, and as a part of this concept, we have taken a considerable interest in the synthesis of this class of biologically active compounds using an environment-friendly, reusable heterogeneous Amberlite IRA 400-Cl resin catalyst. This work further aims to highlight the importance and advantages of these compounds and to compare the experimental data obtained with those of the theoretical calculations made using the density functional theory (DFT) method. Molecular docking studies on the selected compounds were also carried out to study the effectiveness of these compounds in liver fibrosis treatment. Furthermore, we have performed molecular docking studies and an in vitro study of the anticancer activity of dihydropyrano[3,2-c]chromenes and 2-aminobenzochromenes against human colon cancer cells [HT29]. American Chemical Society 2023-02-17 /pmc/articles/PMC9979373/ /pubmed/36873031 http://dx.doi.org/10.1021/acsomega.2c06049 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Cholayil Palapetta, Surya Gurusamy, Harichandran Ganapasam, Sudhandiran Synthesis, Characterization, Computational Studies, Molecular Docking, and In Vitro Anticancer Activity of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene Derivatives |
title | Synthesis, Characterization,
Computational Studies,
Molecular Docking, and In Vitro Anticancer Activity
of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene
Derivatives |
title_full | Synthesis, Characterization,
Computational Studies,
Molecular Docking, and In Vitro Anticancer Activity
of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene
Derivatives |
title_fullStr | Synthesis, Characterization,
Computational Studies,
Molecular Docking, and In Vitro Anticancer Activity
of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene
Derivatives |
title_full_unstemmed | Synthesis, Characterization,
Computational Studies,
Molecular Docking, and In Vitro Anticancer Activity
of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene
Derivatives |
title_short | Synthesis, Characterization,
Computational Studies,
Molecular Docking, and In Vitro Anticancer Activity
of Dihydropyrano[3,2-c]chromene and 2-Aminobenzochromene
Derivatives |
title_sort | synthesis, characterization,
computational studies,
molecular docking, and in vitro anticancer activity
of dihydropyrano[3,2-c]chromene and 2-aminobenzochromene
derivatives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979373/ https://www.ncbi.nlm.nih.gov/pubmed/36873031 http://dx.doi.org/10.1021/acsomega.2c06049 |
work_keys_str_mv | AT cholayilpalapettasurya synthesischaracterizationcomputationalstudiesmoleculardockingandinvitroanticanceractivityofdihydropyrano32cchromeneand2aminobenzochromenederivatives AT gurusamyharichandran synthesischaracterizationcomputationalstudiesmoleculardockingandinvitroanticanceractivityofdihydropyrano32cchromeneand2aminobenzochromenederivatives AT ganapasamsudhandiran synthesischaracterizationcomputationalstudiesmoleculardockingandinvitroanticanceractivityofdihydropyrano32cchromeneand2aminobenzochromenederivatives |